Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_assertion description "[Moreover, high BAK expression correlates with sensitivity of clinical acute myelogenous leukemia to chemotherapy, whereas low BAK levels correlate with resistance and relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_assertion evidence source_evidence_literature NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_assertion SIO_000772 26494789 NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_assertion wasDerivedFrom befree-2016 NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_assertion wasGeneratedBy ECO_0000203 NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1295172.RAfzrB6vm-_CqQg5i9C7WoBaCm_MkT0hakSJvw4Pv_CBE130_provenance.